Engineers Gate Manager LP Eiger Bio Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.28 - $0.93 $311 - $1,033	1,111 Added 8.31%	14,478 $4,000
Q2 2023 Aug 14, 2023	BUY	$0.55 - $1.26 $7,351 - $16,842	13,367 New	13,367 $9,000
Q4 2022 Feb 14, 2023	BUY	$1.02 - $7.48 $13,969 - $102,446	13,696 New	13,696 $16,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $9.23 $106,352 - $125,528	-13,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.44 - $12.66 $110,142 - $165,213	-13,050 Reduced 48.97%	13,600 $120,000
Q4 2020 Feb 16, 2021	BUY	$7.98 - $12.29 $212,667 - $327,528	26,650 New	26,650 $328,000
Q3 2020 Nov 16, 2020	SELL	$7.96 - $12.42 $96,316 - $150,282	-12,100 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$5.4 - $13.37 $72,360 - $179,158	-13,400 Reduced 52.55%	12,100 $116,000
Q1 2020 May 15, 2020	BUY	$4.91 - $14.7 $125,205 - $374,850	25,500 New	25,500 $173,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.